Global Inhalation General Anesthesia Drugs Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Inhalation anesthesia drugs are medications administered through inhalation, typically as gases or vapors, to induce and maintain a state of unconsciousness and pain relief during surgical procedures. These drugs act by depressing the central nervous system, leading to sedation, amnesia, and analgesia, allowing surgical interventions to be performed without causing discomfort or awareness to the patient. Common examples include isoflurane, sevoflurane, and desflurane, each with specific pharmacokinetic properties and clinical applications in anesthesia practice.
The global Inhalation General Anesthesia Drugs market size is projected to grow from US$ 1355 million in 2024 to US$ 1678 million in 2030; it is expected to grow at a CAGR of 3.6% from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Inhalation General Anesthesia Drugs Industry Forecast” looks at past sales and reviews total world Inhalation General Anesthesia Drugs sales in 2023, providing a comprehensive analysis by region and market sector of projected Inhalation General Anesthesia Drugs sales for 2024 through 2030. With Inhalation General Anesthesia Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Inhalation General Anesthesia Drugs industry.
This Insight Report provides a comprehensive analysis of the global Inhalation General Anesthesia Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Inhalation General Anesthesia Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Inhalation General Anesthesia Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Inhalation General Anesthesia Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Inhalation General Anesthesia Drugs.
United States market for Inhalation General Anesthesia Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Inhalation General Anesthesia Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Inhalation General Anesthesia Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Inhalation General Anesthesia Drugs players cover Hengrui, Baxter, Maruishi, AbbVie, Piramal, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Inhalation General Anesthesia Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Inhalation General Anesthesia Drugs market?
What factors are driving Inhalation General Anesthesia Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Inhalation General Anesthesia Drugs market opportunities vary by end market size?
How does Inhalation General Anesthesia Drugs break out by Type, by Application?
Inhalation anesthesia drugs are medications administered through inhalation, typically as gases or vapors, to induce and maintain a state of unconsciousness and pain relief during surgical procedures. These drugs act by depressing the central nervous system, leading to sedation, amnesia, and analgesia, allowing surgical interventions to be performed without causing discomfort or awareness to the patient. Common examples include isoflurane, sevoflurane, and desflurane, each with specific pharmacokinetic properties and clinical applications in anesthesia practice.
The global Inhalation General Anesthesia Drugs market size is projected to grow from US$ 1355 million in 2024 to US$ 1678 million in 2030; it is expected to grow at a CAGR of 3.6% from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Inhalation General Anesthesia Drugs Industry Forecast” looks at past sales and reviews total world Inhalation General Anesthesia Drugs sales in 2023, providing a comprehensive analysis by region and market sector of projected Inhalation General Anesthesia Drugs sales for 2024 through 2030. With Inhalation General Anesthesia Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Inhalation General Anesthesia Drugs industry.
This Insight Report provides a comprehensive analysis of the global Inhalation General Anesthesia Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Inhalation General Anesthesia Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Inhalation General Anesthesia Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Inhalation General Anesthesia Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Inhalation General Anesthesia Drugs.
United States market for Inhalation General Anesthesia Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Inhalation General Anesthesia Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Inhalation General Anesthesia Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Inhalation General Anesthesia Drugs players cover Hengrui, Baxter, Maruishi, AbbVie, Piramal, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Inhalation General Anesthesia Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Sevoflurane
- Isoflurane
- Other
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Hengrui
- Baxter
- Maruishi
- AbbVie
- Piramal
- LAB UNKNOWN
- Viatris
- PT Novell Pharmaceutical
What is the 10-year outlook for the global Inhalation General Anesthesia Drugs market?
What factors are driving Inhalation General Anesthesia Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Inhalation General Anesthesia Drugs market opportunities vary by end market size?
How does Inhalation General Anesthesia Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Inhalation General Anesthesia Drugs Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Inhalation General Anesthesia Drugs by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Inhalation General Anesthesia Drugs by Country/Region, 2019, 2023 & 2030
2.2 Inhalation General Anesthesia Drugs Segment by Type
2.2.1 Sevoflurane
2.2.2 Isoflurane
2.2.3 Other
2.3 Inhalation General Anesthesia Drugs Sales by Type
2.3.1 Global Inhalation General Anesthesia Drugs Sales Market Share by Type (2019-2024)
2.3.2 Global Inhalation General Anesthesia Drugs Revenue and Market Share by Type (2019-2024)
2.3.3 Global Inhalation General Anesthesia Drugs Sale Price by Type (2019-2024)
2.4 Inhalation General Anesthesia Drugs Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Inhalation General Anesthesia Drugs Sales by Application
2.5.1 Global Inhalation General Anesthesia Drugs Sale Market Share by Application (2019-2024)
2.5.2 Global Inhalation General Anesthesia Drugs Revenue and Market Share by Application (2019-2024)
2.5.3 Global Inhalation General Anesthesia Drugs Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Inhalation General Anesthesia Drugs Breakdown Data by Company
3.1.1 Global Inhalation General Anesthesia Drugs Annual Sales by Company (2019-2024)
3.1.2 Global Inhalation General Anesthesia Drugs Sales Market Share by Company (2019-2024)
3.2 Global Inhalation General Anesthesia Drugs Annual Revenue by Company (2019-2024)
3.2.1 Global Inhalation General Anesthesia Drugs Revenue by Company (2019-2024)
3.2.2 Global Inhalation General Anesthesia Drugs Revenue Market Share by Company (2019-2024)
3.3 Global Inhalation General Anesthesia Drugs Sale Price by Company
3.4 Key Manufacturers Inhalation General Anesthesia Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Inhalation General Anesthesia Drugs Product Location Distribution
3.4.2 Players Inhalation General Anesthesia Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR INHALATION GENERAL ANESTHESIA DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Inhalation General Anesthesia Drugs Market Size by Geographic Region (2019-2024)
4.1.1 Global Inhalation General Anesthesia Drugs Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Inhalation General Anesthesia Drugs Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Inhalation General Anesthesia Drugs Market Size by Country/Region (2019-2024)
4.2.1 Global Inhalation General Anesthesia Drugs Annual Sales by Country/Region (2019-2024)
4.2.2 Global Inhalation General Anesthesia Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas Inhalation General Anesthesia Drugs Sales Growth
4.4 APAC Inhalation General Anesthesia Drugs Sales Growth
4.5 Europe Inhalation General Anesthesia Drugs Sales Growth
4.6 Middle East & Africa Inhalation General Anesthesia Drugs Sales Growth
5 AMERICAS
5.1 Americas Inhalation General Anesthesia Drugs Sales by Country
5.1.1 Americas Inhalation General Anesthesia Drugs Sales by Country (2019-2024)
5.1.2 Americas Inhalation General Anesthesia Drugs Revenue by Country (2019-2024)
5.2 Americas Inhalation General Anesthesia Drugs Sales by Type (2019-2024)
5.3 Americas Inhalation General Anesthesia Drugs Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Inhalation General Anesthesia Drugs Sales by Region
6.1.1 APAC Inhalation General Anesthesia Drugs Sales by Region (2019-2024)
6.1.2 APAC Inhalation General Anesthesia Drugs Revenue by Region (2019-2024)
6.2 APAC Inhalation General Anesthesia Drugs Sales by Type (2019-2024)
6.3 APAC Inhalation General Anesthesia Drugs Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Inhalation General Anesthesia Drugs by Country
7.1.1 Europe Inhalation General Anesthesia Drugs Sales by Country (2019-2024)
7.1.2 Europe Inhalation General Anesthesia Drugs Revenue by Country (2019-2024)
7.2 Europe Inhalation General Anesthesia Drugs Sales by Type (2019-2024)
7.3 Europe Inhalation General Anesthesia Drugs Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Inhalation General Anesthesia Drugs by Country
8.1.1 Middle East & Africa Inhalation General Anesthesia Drugs Sales by Country (2019-2024)
8.1.2 Middle East & Africa Inhalation General Anesthesia Drugs Revenue by Country (2019-2024)
8.2 Middle East & Africa Inhalation General Anesthesia Drugs Sales by Type (2019-2024)
8.3 Middle East & Africa Inhalation General Anesthesia Drugs Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Inhalation General Anesthesia Drugs
10.3 Manufacturing Process Analysis of Inhalation General Anesthesia Drugs
10.4 Industry Chain Structure of Inhalation General Anesthesia Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Inhalation General Anesthesia Drugs Distributors
11.3 Inhalation General Anesthesia Drugs Customer
12 WORLD FORECAST REVIEW FOR INHALATION GENERAL ANESTHESIA DRUGS BY GEOGRAPHIC REGION
12.1 Global Inhalation General Anesthesia Drugs Market Size Forecast by Region
12.1.1 Global Inhalation General Anesthesia Drugs Forecast by Region (2025-2030)
12.1.2 Global Inhalation General Anesthesia Drugs Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Inhalation General Anesthesia Drugs Forecast by Type (2025-2030)
12.7 Global Inhalation General Anesthesia Drugs Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Hengrui
13.1.1 Hengrui Company Information
13.1.2 Hengrui Inhalation General Anesthesia Drugs Product Portfolios and Specifications
13.1.3 Hengrui Inhalation General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Hengrui Main Business Overview
13.1.5 Hengrui Latest Developments
13.2 Baxter
13.2.1 Baxter Company Information
13.2.2 Baxter Inhalation General Anesthesia Drugs Product Portfolios and Specifications
13.2.3 Baxter Inhalation General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Baxter Main Business Overview
13.2.5 Baxter Latest Developments
13.3 Maruishi
13.3.1 Maruishi Company Information
13.3.2 Maruishi Inhalation General Anesthesia Drugs Product Portfolios and Specifications
13.3.3 Maruishi Inhalation General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Maruishi Main Business Overview
13.3.5 Maruishi Latest Developments
13.4 AbbVie
13.4.1 AbbVie Company Information
13.4.2 AbbVie Inhalation General Anesthesia Drugs Product Portfolios and Specifications
13.4.3 AbbVie Inhalation General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 AbbVie Main Business Overview
13.4.5 AbbVie Latest Developments
13.5 Piramal
13.5.1 Piramal Company Information
13.5.2 Piramal Inhalation General Anesthesia Drugs Product Portfolios and Specifications
13.5.3 Piramal Inhalation General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Piramal Main Business Overview
13.5.5 Piramal Latest Developments
13.6 LAB UNKNOWN
13.6.1 LAB UNKNOWN Company Information
13.6.2 LAB UNKNOWN Inhalation General Anesthesia Drugs Product Portfolios and Specifications
13.6.3 LAB UNKNOWN Inhalation General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 LAB UNKNOWN Main Business Overview
13.6.5 LAB UNKNOWN Latest Developments
13.7 Viatris
13.7.1 Viatris Company Information
13.7.2 Viatris Inhalation General Anesthesia Drugs Product Portfolios and Specifications
13.7.3 Viatris Inhalation General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Viatris Main Business Overview
13.7.5 Viatris Latest Developments
13.8 PT Novell Pharmaceutical
13.8.1 PT Novell Pharmaceutical Company Information
13.8.2 PT Novell Pharmaceutical Inhalation General Anesthesia Drugs Product Portfolios and Specifications
13.8.3 PT Novell Pharmaceutical Inhalation General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 PT Novell Pharmaceutical Main Business Overview
13.8.5 PT Novell Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
.
Table 1. Inhalation General Anesthesia Drugs Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Inhalation General Anesthesia Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Sevoflurane
Table 4. Major Players of Isoflurane
Table 5. Major Players of Other
Table 6. Global Inhalation General Anesthesia Drugs Sales byType (2019-2024) & (K Units)
Table 7. Global Inhalation General Anesthesia Drugs Sales Market Share byType (2019-2024)
Table 8. Global Inhalation General Anesthesia Drugs Revenue byType (2019-2024) & ($ million)
Table 9. Global Inhalation General Anesthesia Drugs Revenue Market Share byType (2019-2024)
Table 10. Global Inhalation General Anesthesia Drugs Sale Price byType (2019-2024) & (US$/Unit)
Table 11. Global Inhalation General Anesthesia Drugs Sale by Application (2019-2024) & (K Units)
Table 12. Global Inhalation General Anesthesia Drugs Sale Market Share by Application (2019-2024)
Table 13. Global Inhalation General Anesthesia Drugs Revenue by Application (2019-2024) & ($ million)
Table 14. Global Inhalation General Anesthesia Drugs Revenue Market Share by Application (2019-2024)
Table 15. Global Inhalation General Anesthesia Drugs Sale Price by Application (2019-2024) & (US$/Unit)
Table 16. Global Inhalation General Anesthesia Drugs Sales by Company (2019-2024) & (K Units)
Table 17. Global Inhalation General Anesthesia Drugs Sales Market Share by Company (2019-2024)
Table 18. Global Inhalation General Anesthesia Drugs Revenue by Company (2019-2024) & ($ millions)
Table 19. Global Inhalation General Anesthesia Drugs Revenue Market Share by Company (2019-2024)
Table 20. Global Inhalation General Anesthesia Drugs Sale Price by Company (2019-2024) & (US$/Unit)
Table 21. Key Manufacturers Inhalation General Anesthesia Drugs Producing Area Distribution and Sales Area
Table 22. Players Inhalation General Anesthesia Drugs Products Offered
Table 23. Inhalation General Anesthesia Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Inhalation General Anesthesia Drugs Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Inhalation General Anesthesia Drugs Sales Market Share Geographic Region (2019-2024)
Table 28. Global Inhalation General Anesthesia Drugs Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Inhalation General Anesthesia Drugs Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Inhalation General Anesthesia Drugs Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Inhalation General Anesthesia Drugs Sales Market Share by Country/Region (2019-2024)
Table 32. Global Inhalation General Anesthesia Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Inhalation General Anesthesia Drugs Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Inhalation General Anesthesia Drugs Sales by Country (2019-2024) & (K Units)
Table 35. Americas Inhalation General Anesthesia Drugs Sales Market Share by Country (2019-2024)
Table 36. Americas Inhalation General Anesthesia Drugs Revenue by Country (2019-2024) & ($ millions)
Table 37. Americas Inhalation General Anesthesia Drugs Sales byType (2019-2024) & (K Units)
Table 38. Americas Inhalation General Anesthesia Drugs Sales by Application (2019-2024) & (K Units)
Table 39. APAC Inhalation General Anesthesia Drugs Sales by Region (2019-2024) & (K Units)
Table 40. APAC Inhalation General Anesthesia Drugs Sales Market Share by Region (2019-2024)
Table 41. APAC Inhalation General Anesthesia Drugs Revenue by Region (2019-2024) & ($ millions)
Table 42. APAC Inhalation General Anesthesia Drugs Sales byType (2019-2024) & (K Units)
Table 43. APAC Inhalation General Anesthesia Drugs Sales by Application (2019-2024) & (K Units)
Table 44. Europe Inhalation General Anesthesia Drugs Sales by Country (2019-2024) & (K Units)
Table 45. Europe Inhalation General Anesthesia Drugs Revenue by Country (2019-2024) & ($ millions)
Table 46. Europe Inhalation General Anesthesia Drugs Sales byType (2019-2024) & (K Units)
Table 47. Europe Inhalation General Anesthesia Drugs Sales by Application (2019-2024) & (K Units)
Table 48. Middle East & Africa Inhalation General Anesthesia Drugs Sales by Country (2019-2024) & (K Units)
Table 49. Middle East & Africa Inhalation General Anesthesia Drugs Revenue Market Share by Country (2019-2024)
Table 50. Middle East & Africa Inhalation General Anesthesia Drugs Sales byType (2019-2024) & (K Units)
Table 51. Middle East & Africa Inhalation General Anesthesia Drugs Sales by Application (2019-2024) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Inhalation General Anesthesia Drugs
Table 53. Key Market Challenges & Risks of Inhalation General Anesthesia Drugs
Table 54. Key IndustryTrends of Inhalation General Anesthesia Drugs
Table 55. Inhalation General Anesthesia Drugs Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Inhalation General Anesthesia Drugs Distributors List
Table 58. Inhalation General Anesthesia Drugs Customer List
Table 59. Global Inhalation General Anesthesia Drugs SalesForecast by Region (2025-2030) & (K Units)
Table 60. Global Inhalation General Anesthesia Drugs RevenueForecast by Region (2025-2030) & ($ millions)
Table 61. Americas Inhalation General Anesthesia Drugs SalesForecast by Country (2025-2030) & (K Units)
Table 62. Americas Inhalation General Anesthesia Drugs Annual RevenueForecast by Country (2025-2030) & ($ millions)
Table 63. APAC Inhalation General Anesthesia Drugs SalesForecast by Region (2025-2030) & (K Units)
Table 64. APAC Inhalation General Anesthesia Drugs Annual RevenueForecast by Region (2025-2030) & ($ millions)
Table 65. Europe Inhalation General Anesthesia Drugs SalesForecast by Country (2025-2030) & (K Units)
Table 66. Europe Inhalation General Anesthesia Drugs RevenueForecast by Country (2025-2030) & ($ millions)
Table 67. Middle East & Africa Inhalation General Anesthesia Drugs SalesForecast by Country (2025-2030) & (K Units)
Table 68. Middle East & Africa Inhalation General Anesthesia Drugs RevenueForecast by Country (2025-2030) & ($ millions)
Table 69. Global Inhalation General Anesthesia Drugs SalesForecast byType (2025-2030) & (K Units)
Table 70. Global Inhalation General Anesthesia Drugs RevenueForecast byType (2025-2030) & ($ millions)
Table 71. Global Inhalation General Anesthesia Drugs SalesForecast by Application (2025-2030) & (K Units)
Table 72. Global Inhalation General Anesthesia Drugs RevenueForecast by Application (2025-2030) & ($ millions)
Table 73. Hengrui Basic Information, Inhalation General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 74. Hengrui Inhalation General Anesthesia Drugs Product Portfolios and Specifications
Table 75. Hengrui Inhalation General Anesthesia Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 76. Hengrui Main Business
Table 77. Hengrui Latest Developments
Table 78. Baxter Basic Information, Inhalation General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 79. Baxter Inhalation General Anesthesia Drugs Product Portfolios and Specifications
Table 80. Baxter Inhalation General Anesthesia Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. Baxter Main Business
Table 82. Baxter Latest Developments
Table 83. Maruishi Basic Information, Inhalation General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 84. Maruishi Inhalation General Anesthesia Drugs Product Portfolios and Specifications
Table 85. Maruishi Inhalation General Anesthesia Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. Maruishi Main Business
Table 87. Maruishi Latest Developments
Table 88. AbbVie Basic Information, Inhalation General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. AbbVie Inhalation General Anesthesia Drugs Product Portfolios and Specifications
Table 90. AbbVie Inhalation General Anesthesia Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. AbbVie Main Business
Table 92. AbbVie Latest Developments
Table 93. Piramal Basic Information, Inhalation General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Piramal Inhalation General Anesthesia Drugs Product Portfolios and Specifications
Table 95. Piramal Inhalation General Anesthesia Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. Piramal Main Business
Table 97. Piramal Latest Developments
Table 98. LAB UNKNOWN Basic Information, Inhalation General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. LAB UNKNOWN Inhalation General Anesthesia Drugs Product Portfolios and Specifications
Table 100. LAB UNKNOWN Inhalation General Anesthesia Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. LAB UNKNOWN Main Business
Table 102. LAB UNKNOWN Latest Developments
Table 103. Viatris Basic Information, Inhalation General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. Viatris Inhalation General Anesthesia Drugs Product Portfolios and Specifications
Table 105. Viatris Inhalation General Anesthesia Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. Viatris Main Business
Table 107. Viatris Latest Developments
Table 108. PT Novell Pharmaceutical Basic Information, Inhalation General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. PT Novell Pharmaceutical Inhalation General Anesthesia Drugs Product Portfolios and Specifications
Table 110. PT Novell Pharmaceutical Inhalation General Anesthesia Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 111. PT Novell Pharmaceutical Main Business
Table 112. PT Novell Pharmaceutical Latest Developments
LIST OFFIGURES
.
Figure 1. Picture of Inhalation General Anesthesia Drugs
Figure 2. Inhalation General Anesthesia Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Inhalation General Anesthesia Drugs Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Inhalation General Anesthesia Drugs Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Inhalation General Anesthesia Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Inhalation General Anesthesia Drugs Sales Market Share by Country/Region (2023)
Figure 10. Inhalation General Anesthesia Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Sevoflurane
Figure 12. Product Picture of Isoflurane
Figure 13. Product Picture of Other
Figure 14. Global Inhalation General Anesthesia Drugs Sales Market Share byType in 2023
Figure 15. Global Inhalation General Anesthesia Drugs Revenue Market Share byType (2019-2024)
Figure 16. Inhalation General Anesthesia Drugs Consumed in Hospital
Figure 17. Global Inhalation General Anesthesia Drugs Market: Hospital (2019-2024) & (K Units)
Figure 18. Inhalation General Anesthesia Drugs Consumed in Clinic
Figure 19. Global Inhalation General Anesthesia Drugs Market: Clinic (2019-2024) & (K Units)
Figure 20. Inhalation General Anesthesia Drugs Consumed in Other
Figure 21. Global Inhalation General Anesthesia Drugs Market: Other (2019-2024) & (K Units)
Figure 22. Global Inhalation General Anesthesia Drugs Sale Market Share by Application (2023)
Figure 23. Global Inhalation General Anesthesia Drugs Revenue Market Share by Application in 2023
Figure 24. Inhalation General Anesthesia Drugs Sales by Company in 2023 (K Units)
Figure 25. Global Inhalation General Anesthesia Drugs Sales Market Share by Company in 2023
Figure 26. Inhalation General Anesthesia Drugs Revenue by Company in 2023 ($ millions)
Figure 27. Global Inhalation General Anesthesia Drugs Revenue Market Share by Company in 2023
Figure 28. Global Inhalation General Anesthesia Drugs Sales Market Share by Geographic Region (2019-2024)
Figure 29. Global Inhalation General Anesthesia Drugs Revenue Market Share by Geographic Region in 2023
Figure 30. Americas Inhalation General Anesthesia Drugs Sales 2019-2024 (K Units)
Figure 31. Americas Inhalation General Anesthesia Drugs Revenue 2019-2024 ($ millions)
Figure 32. APAC Inhalation General Anesthesia Drugs Sales 2019-2024 (K Units)
Figure 33. APAC Inhalation General Anesthesia Drugs Revenue 2019-2024 ($ millions)
Figure 34. Europe Inhalation General Anesthesia Drugs Sales 2019-2024 (K Units)
Figure 35. Europe Inhalation General Anesthesia Drugs Revenue 2019-2024 ($ millions)
Figure 36. Middle East & Africa Inhalation General Anesthesia Drugs Sales 2019-2024 (K Units)
Figure 37. Middle East & Africa Inhalation General Anesthesia Drugs Revenue 2019-2024 ($ millions)
Figure 38. Americas Inhalation General Anesthesia Drugs Sales Market Share by Country in 2023
Figure 39. Americas Inhalation General Anesthesia Drugs Revenue Market Share by Country (2019-2024)
Figure 40. Americas Inhalation General Anesthesia Drugs Sales Market Share byType (2019-2024)
Figure 41. Americas Inhalation General Anesthesia Drugs Sales Market Share by Application (2019-2024)
Figure 42. United States Inhalation General Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 43. Canada Inhalation General Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 44. Mexico Inhalation General Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 45. Brazil Inhalation General Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 46. APAC Inhalation General Anesthesia Drugs Sales Market Share by Region in 2023
Figure 47. APAC Inhalation General Anesthesia Drugs Revenue Market Share by Region (2019-2024)
Figure 48. APAC Inhalation General Anesthesia Drugs Sales Market Share byType (2019-2024)
Figure 49. APAC Inhalation General Anesthesia Drugs Sales Market Share by Application (2019-2024)
Figure 50. China Inhalation General Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 51. Japan Inhalation General Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 52. South Korea Inhalation General Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 53. Southeast Asia Inhalation General Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 54. India Inhalation General Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 55. Australia Inhalation General Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 56. ChinaTaiwan Inhalation General Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 57. Europe Inhalation General Anesthesia Drugs Sales Market Share by Country in 2023
Figure 58. Europe Inhalation General Anesthesia Drugs Revenue Market Share by Country (2019-2024)
Figure 59. Europe Inhalation General Anesthesia Drugs Sales Market Share byType (2019-2024)
Figure 60. Europe Inhalation General Anesthesia Drugs Sales Market Share by Application (2019-2024)
Figure 61. Germany Inhalation General Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 62.France Inhalation General Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 63. UK Inhalation General Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 64. Italy Inhalation General Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 65. Russia Inhalation General Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 66. Middle East & Africa Inhalation General Anesthesia Drugs Sales Market Share by Country (2019-2024)
Figure 67. Middle East & Africa Inhalation General Anesthesia Drugs Sales Market Share byType (2019-2024)
Figure 68. Middle East & Africa Inhalation General Anesthesia Drugs Sales Market Share by Application (2019-2024)
Figure 69. Egypt Inhalation General Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 70. South Africa Inhalation General Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 71. Israel Inhalation General Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 72.Turkey Inhalation General Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 73. GCC Countries Inhalation General Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Inhalation General Anesthesia Drugs in 2023
Figure 75. Manufacturing Process Analysis of Inhalation General Anesthesia Drugs
Figure 76. Industry Chain Structure of Inhalation General Anesthesia Drugs
Figure 77. Channels of Distribution
Figure 78. Global Inhalation General Anesthesia Drugs Sales MarketForecast by Region (2025-2030)
Figure 79. Global Inhalation General Anesthesia Drugs Revenue Market ShareForecast by Region (2025-2030)
Figure 80. Global Inhalation General Anesthesia Drugs Sales Market ShareForecast byType (2025-2030)
Figure 81. Global Inhalation General Anesthesia Drugs Revenue Market ShareForecast byType (2025-2030)
Figure 82. Global Inhalation General Anesthesia Drugs Sales Market ShareForecast by Application (2025-2030)
Figure 83. Global Inhalation General Anesthesia Drugs Revenue Market ShareForecast by Application (2025-2030)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Inhalation General Anesthesia Drugs Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Inhalation General Anesthesia Drugs by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Inhalation General Anesthesia Drugs by Country/Region, 2019, 2023 & 2030
2.2 Inhalation General Anesthesia Drugs Segment by Type
2.2.1 Sevoflurane
2.2.2 Isoflurane
2.2.3 Other
2.3 Inhalation General Anesthesia Drugs Sales by Type
2.3.1 Global Inhalation General Anesthesia Drugs Sales Market Share by Type (2019-2024)
2.3.2 Global Inhalation General Anesthesia Drugs Revenue and Market Share by Type (2019-2024)
2.3.3 Global Inhalation General Anesthesia Drugs Sale Price by Type (2019-2024)
2.4 Inhalation General Anesthesia Drugs Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Inhalation General Anesthesia Drugs Sales by Application
2.5.1 Global Inhalation General Anesthesia Drugs Sale Market Share by Application (2019-2024)
2.5.2 Global Inhalation General Anesthesia Drugs Revenue and Market Share by Application (2019-2024)
2.5.3 Global Inhalation General Anesthesia Drugs Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Inhalation General Anesthesia Drugs Breakdown Data by Company
3.1.1 Global Inhalation General Anesthesia Drugs Annual Sales by Company (2019-2024)
3.1.2 Global Inhalation General Anesthesia Drugs Sales Market Share by Company (2019-2024)
3.2 Global Inhalation General Anesthesia Drugs Annual Revenue by Company (2019-2024)
3.2.1 Global Inhalation General Anesthesia Drugs Revenue by Company (2019-2024)
3.2.2 Global Inhalation General Anesthesia Drugs Revenue Market Share by Company (2019-2024)
3.3 Global Inhalation General Anesthesia Drugs Sale Price by Company
3.4 Key Manufacturers Inhalation General Anesthesia Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Inhalation General Anesthesia Drugs Product Location Distribution
3.4.2 Players Inhalation General Anesthesia Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR INHALATION GENERAL ANESTHESIA DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Inhalation General Anesthesia Drugs Market Size by Geographic Region (2019-2024)
4.1.1 Global Inhalation General Anesthesia Drugs Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Inhalation General Anesthesia Drugs Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Inhalation General Anesthesia Drugs Market Size by Country/Region (2019-2024)
4.2.1 Global Inhalation General Anesthesia Drugs Annual Sales by Country/Region (2019-2024)
4.2.2 Global Inhalation General Anesthesia Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas Inhalation General Anesthesia Drugs Sales Growth
4.4 APAC Inhalation General Anesthesia Drugs Sales Growth
4.5 Europe Inhalation General Anesthesia Drugs Sales Growth
4.6 Middle East & Africa Inhalation General Anesthesia Drugs Sales Growth
5 AMERICAS
5.1 Americas Inhalation General Anesthesia Drugs Sales by Country
5.1.1 Americas Inhalation General Anesthesia Drugs Sales by Country (2019-2024)
5.1.2 Americas Inhalation General Anesthesia Drugs Revenue by Country (2019-2024)
5.2 Americas Inhalation General Anesthesia Drugs Sales by Type (2019-2024)
5.3 Americas Inhalation General Anesthesia Drugs Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Inhalation General Anesthesia Drugs Sales by Region
6.1.1 APAC Inhalation General Anesthesia Drugs Sales by Region (2019-2024)
6.1.2 APAC Inhalation General Anesthesia Drugs Revenue by Region (2019-2024)
6.2 APAC Inhalation General Anesthesia Drugs Sales by Type (2019-2024)
6.3 APAC Inhalation General Anesthesia Drugs Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Inhalation General Anesthesia Drugs by Country
7.1.1 Europe Inhalation General Anesthesia Drugs Sales by Country (2019-2024)
7.1.2 Europe Inhalation General Anesthesia Drugs Revenue by Country (2019-2024)
7.2 Europe Inhalation General Anesthesia Drugs Sales by Type (2019-2024)
7.3 Europe Inhalation General Anesthesia Drugs Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Inhalation General Anesthesia Drugs by Country
8.1.1 Middle East & Africa Inhalation General Anesthesia Drugs Sales by Country (2019-2024)
8.1.2 Middle East & Africa Inhalation General Anesthesia Drugs Revenue by Country (2019-2024)
8.2 Middle East & Africa Inhalation General Anesthesia Drugs Sales by Type (2019-2024)
8.3 Middle East & Africa Inhalation General Anesthesia Drugs Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Inhalation General Anesthesia Drugs
10.3 Manufacturing Process Analysis of Inhalation General Anesthesia Drugs
10.4 Industry Chain Structure of Inhalation General Anesthesia Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Inhalation General Anesthesia Drugs Distributors
11.3 Inhalation General Anesthesia Drugs Customer
12 WORLD FORECAST REVIEW FOR INHALATION GENERAL ANESTHESIA DRUGS BY GEOGRAPHIC REGION
12.1 Global Inhalation General Anesthesia Drugs Market Size Forecast by Region
12.1.1 Global Inhalation General Anesthesia Drugs Forecast by Region (2025-2030)
12.1.2 Global Inhalation General Anesthesia Drugs Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Inhalation General Anesthesia Drugs Forecast by Type (2025-2030)
12.7 Global Inhalation General Anesthesia Drugs Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Hengrui
13.1.1 Hengrui Company Information
13.1.2 Hengrui Inhalation General Anesthesia Drugs Product Portfolios and Specifications
13.1.3 Hengrui Inhalation General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Hengrui Main Business Overview
13.1.5 Hengrui Latest Developments
13.2 Baxter
13.2.1 Baxter Company Information
13.2.2 Baxter Inhalation General Anesthesia Drugs Product Portfolios and Specifications
13.2.3 Baxter Inhalation General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Baxter Main Business Overview
13.2.5 Baxter Latest Developments
13.3 Maruishi
13.3.1 Maruishi Company Information
13.3.2 Maruishi Inhalation General Anesthesia Drugs Product Portfolios and Specifications
13.3.3 Maruishi Inhalation General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Maruishi Main Business Overview
13.3.5 Maruishi Latest Developments
13.4 AbbVie
13.4.1 AbbVie Company Information
13.4.2 AbbVie Inhalation General Anesthesia Drugs Product Portfolios and Specifications
13.4.3 AbbVie Inhalation General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 AbbVie Main Business Overview
13.4.5 AbbVie Latest Developments
13.5 Piramal
13.5.1 Piramal Company Information
13.5.2 Piramal Inhalation General Anesthesia Drugs Product Portfolios and Specifications
13.5.3 Piramal Inhalation General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Piramal Main Business Overview
13.5.5 Piramal Latest Developments
13.6 LAB UNKNOWN
13.6.1 LAB UNKNOWN Company Information
13.6.2 LAB UNKNOWN Inhalation General Anesthesia Drugs Product Portfolios and Specifications
13.6.3 LAB UNKNOWN Inhalation General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 LAB UNKNOWN Main Business Overview
13.6.5 LAB UNKNOWN Latest Developments
13.7 Viatris
13.7.1 Viatris Company Information
13.7.2 Viatris Inhalation General Anesthesia Drugs Product Portfolios and Specifications
13.7.3 Viatris Inhalation General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Viatris Main Business Overview
13.7.5 Viatris Latest Developments
13.8 PT Novell Pharmaceutical
13.8.1 PT Novell Pharmaceutical Company Information
13.8.2 PT Novell Pharmaceutical Inhalation General Anesthesia Drugs Product Portfolios and Specifications
13.8.3 PT Novell Pharmaceutical Inhalation General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 PT Novell Pharmaceutical Main Business Overview
13.8.5 PT Novell Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
.
Table 1. Inhalation General Anesthesia Drugs Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Inhalation General Anesthesia Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Sevoflurane
Table 4. Major Players of Isoflurane
Table 5. Major Players of Other
Table 6. Global Inhalation General Anesthesia Drugs Sales byType (2019-2024) & (K Units)
Table 7. Global Inhalation General Anesthesia Drugs Sales Market Share byType (2019-2024)
Table 8. Global Inhalation General Anesthesia Drugs Revenue byType (2019-2024) & ($ million)
Table 9. Global Inhalation General Anesthesia Drugs Revenue Market Share byType (2019-2024)
Table 10. Global Inhalation General Anesthesia Drugs Sale Price byType (2019-2024) & (US$/Unit)
Table 11. Global Inhalation General Anesthesia Drugs Sale by Application (2019-2024) & (K Units)
Table 12. Global Inhalation General Anesthesia Drugs Sale Market Share by Application (2019-2024)
Table 13. Global Inhalation General Anesthesia Drugs Revenue by Application (2019-2024) & ($ million)
Table 14. Global Inhalation General Anesthesia Drugs Revenue Market Share by Application (2019-2024)
Table 15. Global Inhalation General Anesthesia Drugs Sale Price by Application (2019-2024) & (US$/Unit)
Table 16. Global Inhalation General Anesthesia Drugs Sales by Company (2019-2024) & (K Units)
Table 17. Global Inhalation General Anesthesia Drugs Sales Market Share by Company (2019-2024)
Table 18. Global Inhalation General Anesthesia Drugs Revenue by Company (2019-2024) & ($ millions)
Table 19. Global Inhalation General Anesthesia Drugs Revenue Market Share by Company (2019-2024)
Table 20. Global Inhalation General Anesthesia Drugs Sale Price by Company (2019-2024) & (US$/Unit)
Table 21. Key Manufacturers Inhalation General Anesthesia Drugs Producing Area Distribution and Sales Area
Table 22. Players Inhalation General Anesthesia Drugs Products Offered
Table 23. Inhalation General Anesthesia Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Inhalation General Anesthesia Drugs Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Inhalation General Anesthesia Drugs Sales Market Share Geographic Region (2019-2024)
Table 28. Global Inhalation General Anesthesia Drugs Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Inhalation General Anesthesia Drugs Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Inhalation General Anesthesia Drugs Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Inhalation General Anesthesia Drugs Sales Market Share by Country/Region (2019-2024)
Table 32. Global Inhalation General Anesthesia Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Inhalation General Anesthesia Drugs Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Inhalation General Anesthesia Drugs Sales by Country (2019-2024) & (K Units)
Table 35. Americas Inhalation General Anesthesia Drugs Sales Market Share by Country (2019-2024)
Table 36. Americas Inhalation General Anesthesia Drugs Revenue by Country (2019-2024) & ($ millions)
Table 37. Americas Inhalation General Anesthesia Drugs Sales byType (2019-2024) & (K Units)
Table 38. Americas Inhalation General Anesthesia Drugs Sales by Application (2019-2024) & (K Units)
Table 39. APAC Inhalation General Anesthesia Drugs Sales by Region (2019-2024) & (K Units)
Table 40. APAC Inhalation General Anesthesia Drugs Sales Market Share by Region (2019-2024)
Table 41. APAC Inhalation General Anesthesia Drugs Revenue by Region (2019-2024) & ($ millions)
Table 42. APAC Inhalation General Anesthesia Drugs Sales byType (2019-2024) & (K Units)
Table 43. APAC Inhalation General Anesthesia Drugs Sales by Application (2019-2024) & (K Units)
Table 44. Europe Inhalation General Anesthesia Drugs Sales by Country (2019-2024) & (K Units)
Table 45. Europe Inhalation General Anesthesia Drugs Revenue by Country (2019-2024) & ($ millions)
Table 46. Europe Inhalation General Anesthesia Drugs Sales byType (2019-2024) & (K Units)
Table 47. Europe Inhalation General Anesthesia Drugs Sales by Application (2019-2024) & (K Units)
Table 48. Middle East & Africa Inhalation General Anesthesia Drugs Sales by Country (2019-2024) & (K Units)
Table 49. Middle East & Africa Inhalation General Anesthesia Drugs Revenue Market Share by Country (2019-2024)
Table 50. Middle East & Africa Inhalation General Anesthesia Drugs Sales byType (2019-2024) & (K Units)
Table 51. Middle East & Africa Inhalation General Anesthesia Drugs Sales by Application (2019-2024) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Inhalation General Anesthesia Drugs
Table 53. Key Market Challenges & Risks of Inhalation General Anesthesia Drugs
Table 54. Key IndustryTrends of Inhalation General Anesthesia Drugs
Table 55. Inhalation General Anesthesia Drugs Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Inhalation General Anesthesia Drugs Distributors List
Table 58. Inhalation General Anesthesia Drugs Customer List
Table 59. Global Inhalation General Anesthesia Drugs SalesForecast by Region (2025-2030) & (K Units)
Table 60. Global Inhalation General Anesthesia Drugs RevenueForecast by Region (2025-2030) & ($ millions)
Table 61. Americas Inhalation General Anesthesia Drugs SalesForecast by Country (2025-2030) & (K Units)
Table 62. Americas Inhalation General Anesthesia Drugs Annual RevenueForecast by Country (2025-2030) & ($ millions)
Table 63. APAC Inhalation General Anesthesia Drugs SalesForecast by Region (2025-2030) & (K Units)
Table 64. APAC Inhalation General Anesthesia Drugs Annual RevenueForecast by Region (2025-2030) & ($ millions)
Table 65. Europe Inhalation General Anesthesia Drugs SalesForecast by Country (2025-2030) & (K Units)
Table 66. Europe Inhalation General Anesthesia Drugs RevenueForecast by Country (2025-2030) & ($ millions)
Table 67. Middle East & Africa Inhalation General Anesthesia Drugs SalesForecast by Country (2025-2030) & (K Units)
Table 68. Middle East & Africa Inhalation General Anesthesia Drugs RevenueForecast by Country (2025-2030) & ($ millions)
Table 69. Global Inhalation General Anesthesia Drugs SalesForecast byType (2025-2030) & (K Units)
Table 70. Global Inhalation General Anesthesia Drugs RevenueForecast byType (2025-2030) & ($ millions)
Table 71. Global Inhalation General Anesthesia Drugs SalesForecast by Application (2025-2030) & (K Units)
Table 72. Global Inhalation General Anesthesia Drugs RevenueForecast by Application (2025-2030) & ($ millions)
Table 73. Hengrui Basic Information, Inhalation General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 74. Hengrui Inhalation General Anesthesia Drugs Product Portfolios and Specifications
Table 75. Hengrui Inhalation General Anesthesia Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 76. Hengrui Main Business
Table 77. Hengrui Latest Developments
Table 78. Baxter Basic Information, Inhalation General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 79. Baxter Inhalation General Anesthesia Drugs Product Portfolios and Specifications
Table 80. Baxter Inhalation General Anesthesia Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. Baxter Main Business
Table 82. Baxter Latest Developments
Table 83. Maruishi Basic Information, Inhalation General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 84. Maruishi Inhalation General Anesthesia Drugs Product Portfolios and Specifications
Table 85. Maruishi Inhalation General Anesthesia Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. Maruishi Main Business
Table 87. Maruishi Latest Developments
Table 88. AbbVie Basic Information, Inhalation General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. AbbVie Inhalation General Anesthesia Drugs Product Portfolios and Specifications
Table 90. AbbVie Inhalation General Anesthesia Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. AbbVie Main Business
Table 92. AbbVie Latest Developments
Table 93. Piramal Basic Information, Inhalation General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Piramal Inhalation General Anesthesia Drugs Product Portfolios and Specifications
Table 95. Piramal Inhalation General Anesthesia Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. Piramal Main Business
Table 97. Piramal Latest Developments
Table 98. LAB UNKNOWN Basic Information, Inhalation General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. LAB UNKNOWN Inhalation General Anesthesia Drugs Product Portfolios and Specifications
Table 100. LAB UNKNOWN Inhalation General Anesthesia Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. LAB UNKNOWN Main Business
Table 102. LAB UNKNOWN Latest Developments
Table 103. Viatris Basic Information, Inhalation General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. Viatris Inhalation General Anesthesia Drugs Product Portfolios and Specifications
Table 105. Viatris Inhalation General Anesthesia Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. Viatris Main Business
Table 107. Viatris Latest Developments
Table 108. PT Novell Pharmaceutical Basic Information, Inhalation General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. PT Novell Pharmaceutical Inhalation General Anesthesia Drugs Product Portfolios and Specifications
Table 110. PT Novell Pharmaceutical Inhalation General Anesthesia Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 111. PT Novell Pharmaceutical Main Business
Table 112. PT Novell Pharmaceutical Latest Developments
LIST OFFIGURES
.
Figure 1. Picture of Inhalation General Anesthesia Drugs
Figure 2. Inhalation General Anesthesia Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Inhalation General Anesthesia Drugs Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Inhalation General Anesthesia Drugs Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Inhalation General Anesthesia Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Inhalation General Anesthesia Drugs Sales Market Share by Country/Region (2023)
Figure 10. Inhalation General Anesthesia Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Sevoflurane
Figure 12. Product Picture of Isoflurane
Figure 13. Product Picture of Other
Figure 14. Global Inhalation General Anesthesia Drugs Sales Market Share byType in 2023
Figure 15. Global Inhalation General Anesthesia Drugs Revenue Market Share byType (2019-2024)
Figure 16. Inhalation General Anesthesia Drugs Consumed in Hospital
Figure 17. Global Inhalation General Anesthesia Drugs Market: Hospital (2019-2024) & (K Units)
Figure 18. Inhalation General Anesthesia Drugs Consumed in Clinic
Figure 19. Global Inhalation General Anesthesia Drugs Market: Clinic (2019-2024) & (K Units)
Figure 20. Inhalation General Anesthesia Drugs Consumed in Other
Figure 21. Global Inhalation General Anesthesia Drugs Market: Other (2019-2024) & (K Units)
Figure 22. Global Inhalation General Anesthesia Drugs Sale Market Share by Application (2023)
Figure 23. Global Inhalation General Anesthesia Drugs Revenue Market Share by Application in 2023
Figure 24. Inhalation General Anesthesia Drugs Sales by Company in 2023 (K Units)
Figure 25. Global Inhalation General Anesthesia Drugs Sales Market Share by Company in 2023
Figure 26. Inhalation General Anesthesia Drugs Revenue by Company in 2023 ($ millions)
Figure 27. Global Inhalation General Anesthesia Drugs Revenue Market Share by Company in 2023
Figure 28. Global Inhalation General Anesthesia Drugs Sales Market Share by Geographic Region (2019-2024)
Figure 29. Global Inhalation General Anesthesia Drugs Revenue Market Share by Geographic Region in 2023
Figure 30. Americas Inhalation General Anesthesia Drugs Sales 2019-2024 (K Units)
Figure 31. Americas Inhalation General Anesthesia Drugs Revenue 2019-2024 ($ millions)
Figure 32. APAC Inhalation General Anesthesia Drugs Sales 2019-2024 (K Units)
Figure 33. APAC Inhalation General Anesthesia Drugs Revenue 2019-2024 ($ millions)
Figure 34. Europe Inhalation General Anesthesia Drugs Sales 2019-2024 (K Units)
Figure 35. Europe Inhalation General Anesthesia Drugs Revenue 2019-2024 ($ millions)
Figure 36. Middle East & Africa Inhalation General Anesthesia Drugs Sales 2019-2024 (K Units)
Figure 37. Middle East & Africa Inhalation General Anesthesia Drugs Revenue 2019-2024 ($ millions)
Figure 38. Americas Inhalation General Anesthesia Drugs Sales Market Share by Country in 2023
Figure 39. Americas Inhalation General Anesthesia Drugs Revenue Market Share by Country (2019-2024)
Figure 40. Americas Inhalation General Anesthesia Drugs Sales Market Share byType (2019-2024)
Figure 41. Americas Inhalation General Anesthesia Drugs Sales Market Share by Application (2019-2024)
Figure 42. United States Inhalation General Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 43. Canada Inhalation General Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 44. Mexico Inhalation General Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 45. Brazil Inhalation General Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 46. APAC Inhalation General Anesthesia Drugs Sales Market Share by Region in 2023
Figure 47. APAC Inhalation General Anesthesia Drugs Revenue Market Share by Region (2019-2024)
Figure 48. APAC Inhalation General Anesthesia Drugs Sales Market Share byType (2019-2024)
Figure 49. APAC Inhalation General Anesthesia Drugs Sales Market Share by Application (2019-2024)
Figure 50. China Inhalation General Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 51. Japan Inhalation General Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 52. South Korea Inhalation General Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 53. Southeast Asia Inhalation General Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 54. India Inhalation General Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 55. Australia Inhalation General Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 56. ChinaTaiwan Inhalation General Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 57. Europe Inhalation General Anesthesia Drugs Sales Market Share by Country in 2023
Figure 58. Europe Inhalation General Anesthesia Drugs Revenue Market Share by Country (2019-2024)
Figure 59. Europe Inhalation General Anesthesia Drugs Sales Market Share byType (2019-2024)
Figure 60. Europe Inhalation General Anesthesia Drugs Sales Market Share by Application (2019-2024)
Figure 61. Germany Inhalation General Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 62.France Inhalation General Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 63. UK Inhalation General Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 64. Italy Inhalation General Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 65. Russia Inhalation General Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 66. Middle East & Africa Inhalation General Anesthesia Drugs Sales Market Share by Country (2019-2024)
Figure 67. Middle East & Africa Inhalation General Anesthesia Drugs Sales Market Share byType (2019-2024)
Figure 68. Middle East & Africa Inhalation General Anesthesia Drugs Sales Market Share by Application (2019-2024)
Figure 69. Egypt Inhalation General Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 70. South Africa Inhalation General Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 71. Israel Inhalation General Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 72.Turkey Inhalation General Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 73. GCC Countries Inhalation General Anesthesia Drugs Revenue Growth 2019-2024 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Inhalation General Anesthesia Drugs in 2023
Figure 75. Manufacturing Process Analysis of Inhalation General Anesthesia Drugs
Figure 76. Industry Chain Structure of Inhalation General Anesthesia Drugs
Figure 77. Channels of Distribution
Figure 78. Global Inhalation General Anesthesia Drugs Sales MarketForecast by Region (2025-2030)
Figure 79. Global Inhalation General Anesthesia Drugs Revenue Market ShareForecast by Region (2025-2030)
Figure 80. Global Inhalation General Anesthesia Drugs Sales Market ShareForecast byType (2025-2030)
Figure 81. Global Inhalation General Anesthesia Drugs Revenue Market ShareForecast byType (2025-2030)
Figure 82. Global Inhalation General Anesthesia Drugs Sales Market ShareForecast by Application (2025-2030)
Figure 83. Global Inhalation General Anesthesia Drugs Revenue Market ShareForecast by Application (2025-2030)
